Capricor Therapeutics
CAPR
#7995
Rank
S$0.37 B
Marketcap
S$8.23
Share price
-4.36%
Change (1 day)
-59.27%
Change (1 year)

Capricor Therapeutics (CAPR) - Total assets

Total assets on the balance sheet as of September 2025 : S$0.16 Billion

According to Capricor Therapeutics 's latest financial reports the company's total assets are S$0.16 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Capricor Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31S$0.23 B198.73%
2023-12-31S$77.57 M15.51%
2022-12-31S$67.15 M20.19%
2021-12-31S$55.87 M22%
2020-12-31S$45.79 M205.67%
2019-12-31S$14.98 M18.6%
2018-12-31S$12.63 M-41.96%
2017-12-31S$21.76 M-19.78%
2016-12-31S$27.13 M19.37%
2015-12-31S$22.73 M26.19%
2014-12-31S$18.01 M156.72%
2013-12-31S$7.01 M5.79%
2012-12-31S$6.63 M273.24%
2011-12-31S$1.77 M-62.37%
2010-12-31S$4.72 M-7.07%
2009-12-31S$5.08 M-44.78%
2008-12-31S$9.2 M-62.58%
2007-12-31S$24.59 M
2006-12-31N/A-100%
2005-12-31S$0 M-54.84%
2004-12-31S$0 M-43.49%
2003-12-31S$0 M4126.08%
2002-12-31S$0 M-90.36%
2001-12-31S$0 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Cytokinetics
CYTK
S$1.85 B 1,036.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
S$4.82 M-97.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$249.59 B 152,398.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$5.52 B 3,273.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$0.83 B 412.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S$7.98 M-95.12%๐Ÿ‡บ๐Ÿ‡ธ USA